India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

The quick commerce major has made the service available in select places including Bengaluru, Mumbai and Hyderabad. Users can ...

The TRUST initiative follows India’s induction into the US-led Minerals Security Finance Network in September last year and ...

The Trump Tariff Shock Hits India Hard 📉 The Indian stock market is experiencing one of its most painful phases, battered by ...

On Tuesday, Amazon Pharmacy announced that it now delivers medicines across all serviceable pin codes in the country, ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

The Nifty Pharma Index has taken a hit, dropping nearly 2% in Friday’s trade. Over the last five days, the index has declined by approximately 4.3%, and on a year-to-date basis, it has fallen by ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

Authorities are planning stricter penalties for retailers and wholesalers as part of efforts to clean up the pharma supply ...

Stock analysts noted Natco Pharma’s missed consensus Q3 estimates on both revenue and Ebitda margin fronts due to lack of ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.